United States: Fiscal & Monetary Policy

The House Appropriations Committee races toward completing all 12 appropriations bills before the July 4 recess, while the Senate remains deadlocked over fundamental spending priorities.

The U.S. Department of Justice's April 2026 rescheduling of medical cannabis to Schedule III has fundamentally altered the regulatory and financial landscape for cannabis businesses.

Congress faces mounting challenges as partisan divisions over the Trump Administration's proposed anti-weaponization fund stall FY26 funding negotiations and complicate the FY27 appropriations process.

The U.S. Department of Justice and DEA have rescheduled FDA-approved and state-licensed medical marijuana products to Schedule III, marking a historic shift in federal drug policy.

Explore critical insights across multiple sectors including Middle East construction challenges amid regional conflict, the intersection of financial reporting valuations and tax compliance, large-scale financial remediation strategies for overdraft fee disputes, and strategic healthcare real estate investment forecasts for 2026. These analyses examine how geopolitical uncertainty, regulatory scrutiny, and evolving market dynamics shape business decisions and operational strategies.

Orders automatic, across-the-board spending cuts to non-exempt direct spending programs for fiscal year 2027, as required by law, with reductions applied uniformly based on calculations issued by the Office of Management and Budget (OMB)...

Our Legislative & Public Policy team is pleased to provide the May 2025 edition of "Capital Snapshot."

The Lobby Shop team turns their focus on the ongoing budget reconciliation process in Congress that will shape the Trump administration's economic agenda.

In this episode of GeTtin' SALTy, host Nikki Dobay is joined by Max Martin, Director of Tax and Fiscal Policy at the Association of Washington Business, to discuss Washington's legislative session...